viously noted (Dick 1971) , the fall in the mortality from scarlet fever and streptococcal sore throats, for which, of course, no routine vaccines have been used, parallels that from whooping-cough and I doubt if whooping-cough vaccine has made any appreciable difference to the death rates from whooping-cough.
When Sydenham described febris scarlatina in 1675, he regarded it as a mild and rarely fatal disease: from the middle to the end of the next century it was a killer but it again became mild at the beginning of the nineteenth century although it remained common. Whooping-cough is now a mild disease but this could be unrelated to the use of vaccines. When the vaccine was first introduced, it was said to be about 80% effective and there was a fall in the number of notifications; subsequently notifications have remained at about one-tenth of the pre-immunization level. The fact that in the mid-1960s the efficacy of much British pertussis vaccine was only about 20-250% (Public Health Laboratory Service 1969) made no difference to the fall in mortality or to the trend in notifications. In the late 1960s, the antigenicity of the vaccine is said to have improved (Perkins 1969) but this seems to have had little or no effect on notifications until last year.
About six years ago, I persuaded a number of Medical Officers of Health to take part in a simple study to test the efficacy of the vaccine in the field on the premise that the vaccine seemed to be doing considerable damage and to be only about 200% effective. We decided that a simple and ethically acceptable study would be to use triple vaccine or diphtheria/tetanus with a nonantigenic pertussis component in several different areas and to compare the notifications of pertussis over several years. The problems of diagnosis of 'what is pertussis' were appreciated but it was considered that an answer on the value of the pertussis component on preventing what has been notified for years as pertussis could be obtained.
However, as the vaccine had been improved, we were dissuaded from getting this trial under way Several cases of convulsions and encephalopathy following pertussis vaccination have been reported during the last forty years. Some of the most influential reports, however, have contained minimal information, such as 'twelve cases of permanent brain damage' by a practitioner who completed Toomey's questionnaire of 1949 and 18 cases of 'irreversible brain damage' mentioned to Dick by unnamed doctors (Dick 1972) . Nevertheless, serious consideration should be given to the extent pertussis vaccination contributes to the incidence of convulsions and encephalopathy in early childhood.
Vaccination ofChildren with a History of Convulsions Livingston (1972) administered pertussis vaccine to 96 children with a history of febrile convulsions. Ten of the children had a convulsion following vaccination. A booster dose of vaccine produced no significant effect in 298 children who had idiopathic epilepsy and only temporarily increased the number of fits in some of 284 children who had secondary epilepsy. Observations on another 13 000 similar children between 1954-1972 appear to confirm his conclusion that a history of convulsions need not be regarded as a contraindication to vaccination. Brody & Sorley (1947) , however, found that each of three spaced injections of pertussis vaccine given to a child who had recovered after encephalitis precipitated a relapse, the last proving fatal. In Britain, a uniovular twin who had a prevaccination history ofconvulsions and transient hemiplegia developed convulsions leading to permanent brain damage after pertussis vaccination (Anderson & Morris 1950) . Her normal healthy sister was unaffected by the vaccine. These cases indicate that it is inadvisable to administer pertussis vaccine to children with a history of brain damage or convulsions, especially as whooping-cough is no longer a prevalent infection in young children.
Background Incidence ofConvulsions
Between 5-7 % of children have at least one convulsion before they are 7 (Ounstead 1971). The first and often the only convulsion commonly occurs when the child is between 6 and 24 months of age. The incidence of first convulsions in infants of that age group is around 1.2 %/annum or 3/100 000 children/day. Since two million doses of diphtheria-tetanus-pertussis (DTP) vac-cine are administered to that age group of children in England and Wales each year, about 60 children have a first convulsion during the first and each subsequent day after vaccination. These convulsions are only chance related to vaccination. The number considerably exceeds the number of reported post-vaccination convulsions. In the 1951-54 Medical Research Council whooping cough vaccine trials (1956), the incidence of postvaccination convulsions was 1.5/100 000 children/ day for twenty-eight post-vaccination days with no significantly raised incidence during any particular period.
Were post-vaccination convulsions brought about by some immunological or pharmacological action of the vaccine, it would be reasonable to expect a time relationship between vaccination and the convulsions, whereas if the convulsions are only chance related no such time relationship would exist. No such time relationship is apparent but I suspect that pertussis vaccine can be responsible for a minority of the convulsions occurring within twenty-four hours of vaccination. Convulsions occurring after that period are only chance related to vaccination. EEGs in pertussis-vaccinated children: Low (1955) found one case of marked diffuse slowing and one of moderate slowing among the post-pertussis vaccination EEGs of 83 children. Pyrexia alone can give rise to slow high voltage waves. Hellstrom (1962) found no significant changes in serial pre-and post-vaccination EEGs of 84 children. Infantile spasms or hypsarrhythmia, with onset during childhood, are most commonly observed for the first time when the children are between 3 and 9 months, that is, the age at which children are routinely vaccinated with DTP. It is understandable therefore that the spasms are occasionally attributed to vaccination. Bower & Jeavons (1960) reported 11 children in whom spasms were first noticed within a week of vaccination -7 after diphtheria-pertussis, 3 after smallpox and 1 after poliovirus vaccine. Their data suggest that smallpox vaccination carried the highest risk since it was administered only once to fewer children than received the 3-4 doses of diphtheria-pertussis vaccine. More realistically, their data indicate how hypsarrhythmia can be mistakenly attributed to vaccination. Breath-holding spells: Severe breath-holding spells leading to frank clonic convulsive movements usually occur after upset or injury to children of over-protective and over-solicitous parents. The average age at first attack is about 12 months and the condition has a strong familial predisposition. Conditions appertaining to the post-vaccination period are clearly conducive to the occurrence of breath-holding spells which are essentially an innocuous disorder.
Febrile convulsions: The difference between a simple febrile convulsion and an epileptic convulsion precipitated by fever appears to be somewhat arbitrary depending mainly on the severity and sequelw of the convulsion. The rate and height of increase in temperature are probably important factors and the children frequently have a familial predisposition to febrile convulsions. The first convulsion usually occurs when the child is between 6 and 18 months, which coincides with the age of routine pertussis vaccination. Since DTP can cause a transient, but usually mild, fever in some infants between two and seven hours after vaccination, it is capable of precipitating febrile convulsions in highly predisposed children. Therefore a minority of convulsions occurring within twenty-four hours of vaccination could be attributed to pyrexia produced by the vaccine. Measures taken to reduce the pyrogenic effect of vaccination should reduce the already remote risk of vaccine-attributable convulsions. 6 Measures for reducing post-vaccination fever: Pertussis vaccine is markedly more pyrogenic when administered into a vein that when given by deep subcutaneous or intramuscular injection. Physicians should therefore ensure that the needle point is not in a vein when inoculating the vaccine. Seepage into venules is reduced by injecting into loose tissues, such as in the gluteal region, rather than into the deltoid, and the injection should be given slowly rather than under considerable pressure. Aluminium adsorbed pertussis vaccine is presumably less pyrogenic than the plain preparation since it causes few minor upsets among infants (Butler et al. 1969) but has the disadvantage of producing more persistent local nodules.
The method of manufacture of a vaccine may affect its reactogenicity (Haire et al. 1967 ) and a reduction in the total number of organisms/dose would be advantageous (Dick 1966) provided the potency was maintained. Vaccines which do not contain thiomersal, which acts as a stabilizer, are particularly liable to cause reactions in children. Vaccines should always be stored as recommended by manufacturers and not be exposed to direct sunlight which decomposes the thiomersal and therefore affects the stability and safety of the vaccine.
Summary. There are several published reports of convulsions and encephalopathy following pertussis vaccination but claims that it produces irreversible brain damage in many children are decried unless they are supported with more information than bare statements.
First convulsions commonly occur in children at the age they are routinely given DTP. In the past, these convulsions of unknown etiology were often attributed to teething which occurs in all children of that age. There is now a tendency to ascribe the convulsions to DTP vaccine which is given to 80 % of children of that age. Relationship between DTP vaccination and a first convulsion is however one of chance only except perhaps for a minority of those occurring within twenty-four hours of vaccination. Measures which could reduce the remote risk of a DTP attributable convulsion within twenty-four hours of vaccination are described. Medical Research Council (1956) Immunization: Balancing the Risks Oxford took part in the series of Medical Research Council whooping-cough vaccine trials which commenced in 1942. By 1951 it was known that a good vaccine giving 85% protection was being used. As a result, routine whooping-cough vaccination has now been practised continuously in Oxford for the last twenty-two years. Virtually all routine vaccinations are undertaken at the City child health clinics which are attended by practically all children during the first year of life. As the uptake of whooping-coughvaccination had already reached 75 % in 1952, has been over 90% since 1961, and topped 97% last year, Oxford must now be one of the best protected areas in the country against this disease.
The beneficial results of this long-sustained whooping-cough vaccination campaign are revealed by a study of the yearly whooping-cough notifications from 1940-72 (Fig 1) . It will be seen that throughout the last fifteen years the incidence has been very low. The The reduced incidence, which particularly affected preschool and school children, has been less marked in the first year of life (Fig 2) . The latter is a reflection of the problem of giving vaccine sufficiently early to protect vulnerable infants.
All whooping-cough notifications have been investigated for evidence of previous vaccination and so far only 386 (1.2 %) out of a total of 26 533 children vaccinated up to the end of 1972 are known to have suffered from whooping-cough (mostly mild cases). With a very high vaccination rate and using a vaccine which at best is only 85 % effective, it must be expected that there will be more cases of whooping-cough occurring amongst the vaccinated than the unvaccinated, and this is what has happened in Oxford during the last eight-years.
Mortality has fallen dramatically. There were 9 deaths from whooping-cough in the decade 1941-50, only one death from 1951-60, and none since. (Oxford's population varied between 98 000 and 110 000 during this period.) Morbidity as evidenced by hospital admissions has also declined substantially. Experience at the Slade Hospital, Oxford, for the period 1942-71 is shown in Table 1 . No serious reaction amongst the 27 000 Oxford children vaccinated to date has been reported.
Because encephalopathy is such an imprecise diagnosis, and because of the problem of deciding whether any adverse reaction following vaccina-
